Extracellular nucleotides signal via a large group of purinergic receptors. Although much is known about these receptors, the mechanism of nucleotide transport out of the cytoplasm is unknown. We developed a functional screen for ATP release to the extracellular space and identified Mcd4p, a 919-amino acid membrane protein with 14 putative transmembrane domains, as a participant in glucose-dependent ATP release from Saccharomyces cerevisiae. This release occurred through the vesicular trafficking pathway initiated by ATP uptake into the Golgi compartment. Both the compartmental uptake and the extracellular release of ATP were regulated by the activity of the vacuolar H ؉ -ATPase. It is likely that the Mcd4p pathway is generally involved in non-mitochondrial ATP movement across membranes, it is essential for Golgi and endoplasmic reticulum function, and its occurrence led to the appearance of P2 purinergic receptors.
Extracellular nucleotides signal via a large group of purinergic receptors. Although much is known about these receptors, the mechanism of nucleotide transport out of the cytoplasm is unknown. We developed a functional screen for ATP release to the extracellular space and identified Mcd4p, a 919-amino acid membrane protein with 14 putative transmembrane domains, as a participant in glucose-dependent ATP release from Saccharomyces cerevisiae. This release occurred through the vesicular trafficking pathway initiated by ATP uptake into the Golgi compartment. Both the compartmental uptake and the extracellular release of ATP were regulated by the activity of the vacuolar H ؉ -ATPase. It is likely that the Mcd4p pathway is generally involved in non-mitochondrial ATP movement across membranes, it is essential for Golgi and endoplasmic reticulum function, and its occurrence led to the appearance of P2 purinergic receptors.
Extracellular nucleotides, such as ATP and ADP, are signaling molecules in virtually all tissues (1-3). They activate two families of P2 purinergic receptors, the G-protein-coupled P2Y receptors (currently P2Y 1,2 4,6,11,12 ) and the ligand-gated ion channel P2X receptors (currently P2X [1] [2] [3] [4] [5] [6] [7] , that are involved in a large variety of physiological and pathological processes.
In addition to the release of intracellular nucleotides by disrupted cells, there are several physiological export pathways. The one best characterized involves the fusion of secretory vesicles and granules that contain ATP and other nucleotides (4) with the plasma membrane (1, 3, (5) (6) (7) (8) . Exocytotic release of such ATP pools results in both paracrine and autocrine activation of P2 purinergic receptors and triggers a number of cellular responses including platelet aggregation, pain initiation, and inflammation (1, 3, 7, 9, 10) .
Mechanical perturbation of cells, such as shear stress, membrane stretching, and hypo-osmotic cell swelling, brings about ATP release from endothelial cells (3, 11) , epithelial cells (12) , hepatocytes (13) , and Xenopus oocytes (14) . This release is important for bladder volume sensing and hearing (3, 11) . Putative ATP channels, regulated by tyrosine and Rho kinases, have been implicated in mediating this type of ATP release (11, 15) .
Many cells including epithelial cells (16) , osteoblasts (17) , Xenopus oocytes (14) , and yeast (18) release ATP constitutively.
Acting via P2Y receptors, ATP released from osteoblasts serves as a potent stimulator of parathyroid hormone-induced activation of bone remodeling (17) , while that from epithelial cells regulates electrolyte and fluid secretion (19, 20) . A decrease in ATP release from epithelial cells is believed to contribute to the pathophysiology of cystic fibrosis and glaucoma (20, 21) . It is not known whether the constitutive and the mechanically induced ATP release are mediated by vesicular fusion or by direct movement of ATP across the plasma membrane.
Movement of ATP into endoplasmic reticulum (ER) 1 and Golgi membranes has been characterized, and the putative transporters have been purified (22, 23) . In both cases, the movement was described as an exchange of ATP for ADP. The putative ER transporter, Sac1p, was found to be a regulator of ATP transport (24) , while the Golgi transporter has not been identified.
ATP-binding cassette proteins (ABC proteins), such as Pglycoprotein (25, 26) and cystic fibrosis-transmembrane conductance regulator (CFTR) protein (27) , have been suggested to act as ATP channels in epithelial cells. However, it is unknown whether they can conduct ATP themselves or regulate an associated ATP channel (3, 8, 19, 28) . Connexin, a gap junction protein, has also been implicated in ATP release (29) , but it has not been shown to mediate ATP release directly either. Expression of CD39 in Xenopus oocytes is associated with an ATPassociated current, suggesting the involvement of CD39 in ATP movement (30) . Thus far, the protein components involved in nucleotide export have not been identified conclusively and the molecular mechanisms for the process remain obscure.
To directly tackle this question, we have developed a novel functional screen that provides an effective system to identify genes involved in ATP transport. A highly conserved Mcd4p protein family, present in yeast and man, was found to mediate ATP release from cells. Interestingly, Mcd4p-mediated ATP release occurred through the membrane-trafficking pathway initiated by ATP uptake into the Golgi. Both the ATP uptake and the extracellular release were dependent on the activity of the vacuolar H ϩ -ATPase. We suggest that this pathway is the mechanism for ATP release in eukaryotic cells.
EXPERIMENTAL PROCEDURES
Strains, Media, and Chemicals-Saccharomyces cerevisiae strains used were RH407-6b (MAT␣ ade2 his3 leu2 ura3 trp1 bar1) (31) (34) . Standard rich (YPD) and complete synthetic minimal adenine, tryptophan, uracil, or methionine drop-out media were used (35) . Pyruvate, atractyloside, Dowex 8 (chloride form, 100 -200 mesh), bafilomycin A, and NADH were purchased from Sigma. Brefeldin A was purchased from ICN Biomedicals (Sosta Mesa, CA).
Functional Screen for Nucleotide Export-CTY182 cells (10 5 ) were transformed with a yeast genomic library in Yep24 (36) and grown on synthetic minimal medium lacking uracil, adenine, and methionine. Colonies were replicated onto plates with the same medium covered with a lawn of RH407-6B cells containing plasmid TbAT1 (31) and were grown for 10 days at 30°C. Plasmid DNA (ATP1-3) from colonies surrounded with tiny pink colonies was isolated, sequenced, and analyzed on the yeast genomic data base. ATP1-3 contained a roughly 15-kb DNA insert including the MCD4, PIR1, and PIR3 genes.
Measurement of ATP Release-Yeast cells were grown at 30°C overnight on complete minimum uracil drop-out medium containing 2% glucose (A 650 Ϸ 2.5) and then transferred to fresh medium at a cell density of roughly 6 ϫ 10 7 cells ml Ϫ1 (A 650 ϭ 1 corresponded to 1.6 ϫ 10 7 cells ml Ϫ1 ). The cells were kept at 30°C on a rotatory shaker. Aliquots of 0.5 ml were taken at each time point, as indicated in Figs. 3B, 4 , B and C, and 5B, and centrifuged at 10,000 rpm for 5 min. To determine the ATP content of the supernatants, an aliquot of 100 l of the sample was mixed with 100 l of a luciferase/luciferin reagent (ENLITEN TM ATP assay system, Promega, Madison, WI) and the light emission was read with a luminometer (model TD-20/20, Turner Designs, Sunnyvale, CA). An ATP standard curve was obtained under the same conditions with the provided ATP standards. Isocitrate dehydrogenase activity of the cell suspensions was determined according to Crotti et al. (37) with the Sigma Diagnostics isocitrate dehydrogenase kit (Sigma) by measuring the rate at which NADP was converted to NADPH ϩ . To cells suspended in 1 ml of isocitrate buffer at a density of 10 8 cells/ml, 1 ml of NADP solution containing 0.6 mg of NADP was added. At intervals, a 0.25-ml aliquot of the suspension was centrifuged at 5000 ϫ g to pellet the cells and the A 340 of the supernatant solution was measured with a Beckman DU-50 spectrophotometer. The integrity of the cells was determined by incubation of the cells with 0.01% methylene blue (w/v). Total cells and blue cells were counted.
Subcellular Fractionation-Subcellular fractionation was done as described by Berninsone et al. (38) . Cells were grown to A 600 ϭ 4 in medium at 30°C, isolated by centrifugation, and converted to spheroplasts. Spheroplasts were lysed by dilution in hypo-osmotic buffer, and the lysate was centrifuged at 1000 ϫ g for 10 min to remove large particles. The supernatant was centrifuged at 13,000 ϫ g (P13) and 120,000 ϫ g (P120) for 20 and 60 min, respectively. The P13 and P120 pellets were suspended in 10 mM triethanolamine, pH 7.2, 0.8 M sorbitol, 1 mM EDTA.
Plasmids and Antibodies-To overexpress MCD4, GPI7, and GPI13 genes in yeast, PCR fragments generated from chromosomal DNA of YPH500 with the following primers were cloned into pVT101U (39) . tag and the GPI7 open reading frame (nucleotides 2467-2490)) were used for GPI7 (resulting plasmid pGZ168). Primer 180 (5Ј-CCGCTCG-AGGTAACCATGGATGAAAAGACAATTAAAAAG-3Ј containing a XhoI site and a sense sequence of the GPI13 open reading frame (nucleotides 1-24)) and primer 181 (5Ј-GGGGATCCCTACAAGTCCTCTTCAGATA-TCAGCTTTTGCTCTTTCCAAAAAATGTCATTTATGTG-3Ј containing a BamH1 site, an antisense sequence of a myc tag and the GPI13 open reading frame (nucleotides 3028 -3051)) were used for GPI13 (resulting plasmid pGZ169). To overexpress a His-tagged N-terminal soluble domain of Mcd4p (sMcd4p) for antisera generation, a PCR fragment generated with primer 194 (5Ј-CGCGGATCCGACCACTTTTGATAAA-GTCACT-3Ј containing a BamHI site and a sense sequence of the MCD4 open reading frame (nucleotides 187-207)), primer 195 (5Ј-AACTG-CAGTCAAGTTCTAATGAATCTCCAATTATA-3Ј containing a PstI site and an antisense sequence of the MCD4 open reading frame (nucleotides 1348 -1371)), and the template pGZ170 was cloned into pTrcHisB (Invitrogen). The resulting plasmid pGZ177 was transformed into Escherichia coli DH5␣, and overproduction and purification of the His 6 -sMcd4p protein were performed as described previously (40) . Rabbit polyclonal antisera for Mcd4p were raised against purified His 6 -sMcd4p proteins (Lampire Biological Laboratories, Pipersville, PA). To make the vector to express the human MCD4 gene (hMCD4), a PCR fragment was generated with primer 189 (5Ј-CCCAAGCTTATGCTGCTGTTCTT-TACTTTGGGA-3Ј containing a HindIII site and a sense sequence of the hMCD4 open reading frame (nucleotides1-24)), primer 190 (5Ј-CG-GAATTCCATGAAGTGACTTTTGGGTTTGCC-3Ј containing an EcoRI site and an antisense sequence of the hMCD4 open reading frame (nucleotides 2770 -2793)), and the human testis marathon-ready cDNA (Clontech, Palo Alto, CA). The PCR fragment was cloned into pCDNA3.1 (Invitrogen). To overexpress hMCD4 in yeast, a PCR fragment was generated with primer 191 (5Ј-CCCAAGCTTGTAACCAT-GCTGCTGTTCTTTACTTTGGGA-3Ј containing a HindIII site and a sense sequence of hMCD4 open reading frame (nucleotides 1-24)), primer 192 (5Ј-CGCGGATCCTCAATGGTGATGGTGATGATGACC-3Ј containing a BamHI site and an antisense sequence of pcDNA3.1A (nucleotides 1048 -1073)), and the template pGZ174. The fragment was cloned into pVT101U (pGZ175).
RESULTS

Development of a Functional Screen to Identify Genes Involved in
Nucleotide Release-The screen is based on the use of a yeast strain that is able to sense the presence of adenine nucleotides in the medium (Fig. 1A) . We took advantage of the fact that the ade2 mutant strain of S. cerevisiae is not able to grow in an adenine-deficient medium. This strain cannot utilize exogenous adenosine and adenine nucleotides since yeast cells do not take up these molecules (31) . However, when nucleoside transporter TbAT1 was expressed in the strain, it was able to grow with adenosine as a sole purine source (Fig. 1B ) (31) . Furthermore, the modified yeast strain could also grow in the adenine-deficient medium when supplemented with AMP, ADP, or ATP (Fig. 1B) since adenine nucleotides can be hydrolyzed to adenosine by acid phosphatases at the cell surface (41) . In addition, the yeast strain developed a pink color when grown in these media, making it an ideal indicator for functional screening. Fig. 2A shows a schematic of the functional screen. A yeast expression library was transformed into a wild type host strain. The transformants were replicated onto adenine-deficient plates that had been covered with a lawn of adenine nucleotidesensing cells. Colonies from cells overexpressing ATP transporters or their activators were identified by a ring of small pink colonies representing the nucleotide-sensing cells that grew in the presence of adenosine (Fig. 2B) . When cells of and YMR4/ATP1-3 were grown in uracil drop-out medium at 30°C overnight. ATP present in the extracellular medium was measured as described under "Experimental Procedures" (n ϭ 3).
strain YMR4 that lack expression of periplasmic acid phosphatases (41) were transformed with one of the positive clones (called ATP1-3), they secreted six times more ATP than control yeast cells as measured with a luciferin/luciferase assay (Fig. 2C) .
A Highly Conserved Mcd4p Protein Family Mediates Glucosedependent Extracellular ATP Release-Further sequence analysis indicated that the ATP1-3 clone contained the entire MCD4 gene of S. cerevisiae, which encodes a 919-amino acid membrane protein with 14 putative transmembrane domains and a large exocytoplasmic domain containing motifs conserved in phosphodiesterases and nucleotide pyrophosphatases (Fig.  3A) (34) . Yeast cells transformed with the pVT101U vector containing the MCD4 gene placed behind a constitutive promoter expressed Mcd4p (Fig. 3B, insert) and released 20 times more ATP than did cells transformed with vector alone (Fig.  3B) . In cells containing a temperature-sensitive mutant of Mcd4p, mcd4 -174 (kindly provided by Peter Orlean), ATP efflux was strongly reduced at semi-permissive temperature (Fig.  3C) . In this figure, SEY6210 is the wild type strain, whereas GY1450 and GY1451 are two mcd4 -174 mutant strains. Mcd4p-mediated ATP release was dependent on the presence of glucose (Fig. 3D ), in accordance with the report that ATP release is stimulated by a rise in intracellular cAMP brought about by the addition of glucose to starved cells (18) .
MCD4 is an essential gene that was originally identified as a component involved in cell morphology changes during the cell cycle (42) and in the glycosylphosphatidylinositol (GPI) anchor synthesis pathway (34) . Recent studies (43) (44) (45) (46) (47) (48) revealed that Ͼ14 Mcd4p homologues have been found in different species forming a highly conserved protein family ranging from yeast to man (Fig. 4A) . Phylogenetic analysis indicated that the entire family can probably be grouped into three subfamilies according to the similarity of their protein sequences to Mcd4p, n ϭ 3) . The cells were grown at 30°C semi-permissive temperature. D, Mcd4p-mediated ATP release is glucose-dependent. YMR4/pGZ170 (overexpressing MCD4) was grown in uracil drop-out medium at 30°C in the presence of 2% glucose (Glucose) or 2% galactose (Galactose), or in the absence of a carbon source (None). Extracellular ATP release was measured as described under "Experimental Procedures" (n ϭ 3).
Gpi7p (43) , and Gpi13p (46, 47) in budding yeast (Fig. 4A) . To determine whether other members of this family are also involved in ATP release, yeast GPI13 and GPI7 as well as the human MCD4 homologue (hMCD4) were overexpressed in YMR4 cells. Gpi13p and Gpi7p stimulated ATP release by 7-and 3-fold, respectively (Fig. 4B ) and hMcd4p expression enhanced ATP release by 4-fold (Fig. 4C ). It appears that the Mcd4p family represents a novel group of membrane proteins involved in ATP release. This is consistent with the previous classification of this family as a putative permease family (49) .
Does Expression of Mcd4p
Change the Membrane Permeability?-The increase in ATP release was not due to cell lysis or general disruption of plasma membrane integrity because the fraction of cells (Ͼ0.95), which remain colorless, as measured by a methylene blue assay was the same as that in cells containing the vector alone. Also, isocitrate dehydrogenase activity, a measure of membrane permeability (37) , in suspensions of cells expressing Mcd4p and of control cells was not detectable, indicating that the plasma membrane of the cells expressing Mcd4p was not more leaky than that of the control cells (data not shown).
ATP Release Occurs through the Membrane-trafficking Pathway Initiated by Mcd4p-dependent ATP Uptake in the Golgi-
Mcd4p is localized mainly in the ER (34); however, upon overexpression it is present in the Golgi as well (Fig. 7) . Since it is likely that Mcd4p is present in both compartments, we believe that it is involved in ATP uptake into these intracellular compartments where it is essential for protein folding and phosphorylation during protein translocation and maturation. ATP transport activities in the ER and the Golgi have been reported previously (22) (23) (24) . To directly test this possibility, we measured ATP uptake into membrane fractions isolated from cells transformed with an expression plasmid containing the MCD4 gene. As shown in Fig. 5A , overexpression of Mcd4p stimulated in vitro ATP uptake into the Golgi-enriched P120 membrane fraction, although there was a small effect in the ER-enriched P13 membrane fraction. This result suggested the possibility that extracellular ATP release mediated by Mcd4p occurred via the membrane-trafficking pathway. To directly test this possibility, we examined the effect on ATP release of brefeldin A, a substance that blocks vesicle movement between the ER and Golgi. Yeast cells, unlike animal cells, are resistant to brefeldin A; however, the erg6⌬ yeast mutant, which is defective in the biosynthesis of membrane sterols, has been reported to be susceptible to brefeldin A (50, 51). As shown in Fig. 5B , ATP release from erg6⌬ mutant cells overexpressing Mcd4p was significantly inhibited by 25 g/ml brefeldin A, indicating that Mcd4p-mediated ATP release occurs at least in part through the secretory pathway.
The stimulation of ATP release through the secretory pathway by Mcd4p could simply be a consequence of overexpression of a secreted or membrane protein on the secretory pathway. Overexpression of secreted cell wall proteins Pir1p and Pir3p (52), Golgi membrane protein Gda1p (33), and t-SNARE SS02 (53) with a single transmembrane domain, rat plasma membrane protein CD39 (54) , and yeast serine palmitoyltransferase Lcb1p (55) with two transmembrane domains and polytopic membrane protein mouse Mdr3 (56) had no effect on ATP release (Table I ). The stimulation of ATP transport was specific for Mcd4p expression.
Mcd4p, Gpi7p, and Gpi13p stimulates ATP release. ATP release from YMR4/pVT101 (Vector), YMR4/pGZ168 (GPI7), and YMR4/pGZ169 (GPI13) was measured as described under "Experimental Procedures" (n ϭ 3). C, overexpression of human MCD4 also stimulates ATP release. ATP release from YMR4/pVT101U (Vector) and YMR4/pGZ175 (hMCD4) were measured as described (n ϭ 3). FLJ20265 (NP060203.1) . The relationships were derived from neighbor-joining weighted progressive alignments of the protein sequences using the ClustalW program (68) . Phylogenetic analysis of the alignment was performed with the software PAUP, version 4.0b1 for Macintosh (Ref. 69) . A full heuristic search was performed using 500 replications with a bootstrap confidence interval of 50. Branch swapping was performed by stepwise addition using the tree bisection-reconnection swapping algorithm. 100 trees were retained at each step. B, overexpression of two budding yeast homologues of
Both ATP Uptake in the Golgi and the Extracellular Release Are Regulated by the V-ATPase-If
Mcd4p-mediated ATP release occurs through the secretory pathway, deletion of YND1, which codes for a Golgi ecto-ATPase (58), should stimulate ATP efflux. As shown in Fig. 5C , there was increased ATP efflux in ynd1 Ϫ cells compared with the parental strain, whereas deletion of GDA1, which codes for the Golgi GDPase (33), had no effect on ATP efflux. Conversely, overexpression of Ynd1p should decrease ATP efflux because of increased ATP degradation in the Golgi. Surprisingly, in cells overexpressing Ynd1p, ATP efflux was stimulated (Fig. 6A) and ATP uptake in the Golgi vesicle from these cells was also increased (Fig. 6B) . This apparently contradictory result arises from the interaction between Ynd1p and Vma13p, a peripheral activator subunit of the vacuolar H ϩ -ATPase (V-ATPase) that we discovered through a yeast two-hybrid screen (59) . It seemed likely that overexpression of Ynd1p would result in the recruitment of the V-ATPase to the Golgi with a consequent increase in the H ϩ gradient set up by this complex (60) to provide the driving force for ATP transport and down-regulation of the ATPase activity of Ynd1p (59) . Indeed, as shown in Fig. 6C , overexpression of Ynd1p changed the distribution of the V-ATPase subunits Vma13p and Vma1p from the vacuole-enriched P13 fraction to the Golgi-enriched P120 fraction, supporting relocation of the V-ATPase complex to the Golgi. However, there is no change in the distribution of vacuolar alkaline phosphatase Pho8p, indicating that expression of Ynd1p does not cause a change in fractionation of the membranes. Bafilomycin, which inhibits the activity of the V-ATPase, also inhibited ATP uptake into Golgi vesicles (Fig. 6D) . In addition, inactivation of the VATPase by deletion of VMA1 or mutation of the essential glutamic acid 286 in Vma1p (32) caused a decrease in ATP efflux (Fig. 6E) . Expression of Mcd4p and Ynd1p together in yeast cells does not bring about a greater ATP release than is obtained with either protein alone (Fig. 7) , nor does expression of one protein affect the localization of the other. This indicates of BY4742-YML008C/pGZ170 were diluted 1:5 in fresh uracil drop-out medium, grown at 30°C for 5 h, and resuspended in the same medium to a final concentration of around 3.5 A 650 /ml. 25 g/ml brefeldin A were added to the medium. The reactions were started at room temperature by adding 4% glucose. Extracellular ATP was measured as described under "Experimental Procedures." C, deletion of YND1 stimulates ATP release. Overnight cultures of CTY182 (wild type), CTY182-A (ynd1⌬), G2-6 (wild type), and G2-7 (gda1⌬) in YPD at 30°C were measured for their extracellular ATP (n ϭ 4).
FIG. 5.
Mcd4p-mediated ATP release occurs through the membrane-trafficking pathway initiated by Mcd4p-dependent ATP uptake in the Golgi. A, overexpression of Mcd4p stimulates ATP uptake into the ER and Golgi. P13 (ER) and P120 (Golgi) membrane fractions were isolated from YMR4/pG170 (expressing Mcd4p) and YMR4/pVT101U (Vector) cells as described previously (38) and resuspended in 10 mM triethanolamine, pH 7.2, 0.8 M sorbitol, 1 mM EDTA. The in vitro ATP transport assays with [ 3 H]ATP were carried out for 5 min essentially as described previously (22) (n ϭ 4) . B, brefeldin A significantly blocks Mcd4p-mediated ATP release. Overnight cultures ) , and YMR4/pGZ179 (overexpressing Gda1p) in uracil drop-out media at 30°C were measured for their extracellular ATP (n ϭ 4). B, overexpression of Ynd1p stimulates ATP uptake in the Golgi. P120 membrane fractions from YMR4/pGZ148 (expressing Ynd1p) and YMR4/pVT101U (Vector) cells were used for ATP uptake assays, which were done (as in Fig. 5, panel A) for 5 min (n ϭ 3). C, overexpression of Ynd1p relocalizes the V-ATPase from the vacuole to the Golgi compartments. 50 g of P13 and P120 membrane fractions of YPH500/pVT101U (Vector) and YPH500/pGZ148 (expressing Ynd1p) were separated in a 10% SDS-PAGE gel. Anti-Vma13p (1:2000), anti-Vma1p (1:1000), and monoclonal anti-Pho8p (1:100) (Molecular Probes) were used for immunoblotting. Both Vma13p and Vma1p are present in the Golgi fraction when YND1 is expressed. There is no change in the distribution of vacuolar alkaline phosphatase Php8p. D, bafilomycin inhibits ATP uptake in the Golgi. P120 membrane fractions from YMR4/pGZ170 (expressing Mcd4p) and YMR4/pGZ148 (expressing Ynd1p) were used for the assays. 3 M bafilomycin were added to the ATP uptake assays, and Me 2 SO was added as a control (n ϭ 4). E, inactivation of the V-ATPase decreases ATP release. Overnight cultures of SF838 -5A␣ (vma1⌬), URA-VMA1-WT (VMA1), and URA-VMA1-E286Q in YPD at 30°C were measured for extracellular ATP (n ϭ 3).
that there is a limit to the uptake of ATP in the Golgi and its subsequent release extracellularly. All of these results suggest that the V-ATPase complex regulates both ATP uptake in intracellular compartments and extracellular release. This conclusion is supported by the evidence that ATP transport into chromaffin granule ghosts is driven by the electrical component of the proton gradient created by the V-ATPase (4).
We suggest that Mcd4p, a membrane protein with 14 transmembrane segments, is the vehicle for ATP movement into intracellular compartments. The V-ATPase creates the protomotive force required to drive ATP transport, and it decreases the ATPase activity of Ynd1p. ATP is released extracellularly through the vesicular-trafficking pathway, which may be a common mechanism for constitutive ATP release present in many cell types (14, 16) .
DISCUSSION
Although the presence of ATP and other nucleotides in mitochondria, the ER and Golgi compartments, secretory vesicles and granules, and the extracellular space has been known for considerable time, only one nucleotide transport pathway has been described, the mitochondrial ADP/ATP exchanger (61) . No other nucleotide transporters have yet been identified. With the functional screen described in this study, we have discovered the Mcd4p protein family that mediates ATP release from cells (Figs. 1-4) . The presence of Mcd4p in Golgi membranes indicates that the protein stimulates ATP uptake in this compartment and that ATP is released extracellularly by movement through the secretory pathway (Fig. 5) . Uptake into the Golgi compartment requires the activity of the V-ATPase as the uptake is inhibited by bafilomycin and enhanced by recruitment of the V-ATPase to the Golgi membranes (Fig. 6) .
Although the necessity of luminal ATP in the ER and Golgi for protein folding, targeting, and phosphorylation is generally recognized (22, 23) , our results suggest that luminal ATP is also the source of ATP released extracellularly in many cell types (14, 16) . It is likely that the Mcd4p family is responsible for the uptake of ATP in the Golgi and its release into the extracellular space.
The involvement of the V-ATPase in ATP uptake in the Golgi and its extracellular release is supported by the inhibition of ATP uptake in membrane vesicles by bafilomycin and by the decrease in ATP release in yeast cells lacking a functional V-ATPase. Interestingly, ATP accumulation into chromaffin granules also requires the protomotive force generated by the V-ATPase (4). This observation suggests that mammalian Mcd4p protein family members may also have a role in ATP uptake in secretory vesicles and granules within neurons and secretory cells.
In yeast, the V 1 domain of the V-ATPase dissociates promptly from the V 0 domain in response to substitution of galactose for glucose or depletion of the carbon source from the culture medium (62) . The addition of glucose also induces rapid reassembly of the enzyme from the previously synthesized V 1 and V 0 domains. In this way, the V-ATPase alters the acidification in yeast intracellular organelles in response to the change in cytoplasmic conditions affected by the carbon source (62) . Because Mcd4p-mediated ATP uptake in the Golgi is regulated by the activity of V-ATPase, this uptake would also be modulated by the carbon source. This notion is supported by the observation that ATP release is a glucose-dependent process (Fig. 3) .
The Mcd4p protein family was discovered as a requirement for ethanolamine phosphate (EtN-P) transfer during GPI anchor synthesis (34, 43, 46, 47) . Mcd4p and Gpi13p are essential for growth and are localized in intracellular membranes (34, 46, 47) , whereas Gpi7p is not essential and the bulk of it is located in the plasma membrane (43) . Here we show that these proteins are also involved in ATP transport. Interestingly, Sac1p, a membrane protein with a single transmembrane segment that regulates ATP/ADP exchange in the ER, is also involved in phospholipid metabolism (24) . All of these results suggest that phospholipid metabolism is linked to ATP transport into the lumen of intracellular compartments. One possibility is that the EtN-P transfer reaction may require luminal ATP. Although EtN-P addition to the growing GPI anchor occurs in the luminal leaflet of ER membrane (34, 43, 47, 47, 63) , phosphatidylethanolamine, the likely donor of EtN-P to the GPI anchor (64) , is synthesized on the cytoplasmic side of the ER membrane (65) . It has been speculated that the Mcd4p protein family is responsible for flipping phosphatidylethanolamine from the cytoplasmic to the luminal leaflet of the ER membrane (46) . It is possible that phosphatidylethanolamine and ATP might symport together into the ER lumen through the Mcd4p family.
The Mcd4p protein family members all possess Ͼ12 putative membrane-spanning domains in addition to a large extracellu- lar domain containing conserved phosphodiesterases and nucleotide pyrophosphatases motifs (Fig. 3A) . The topological arrangement of these proteins is similar to that of protonmonoamine antiporters that concentrate monoamine neurotransmitters into synaptic vesicles (66) . This is consistent with Mcd4p's requirement for the protomotive force in ATP uptake. Further investigations are required to understand the exact roles of Mcd4p in ATP transport, its interplay with the V-ATPase complex, and its relationship with phospholipid metabolism.
Extracellular ATP serves as a fast and potent extracellular signaling molecule that triggers a broad range of biological processes. How did this happen? If ATP release is a consequence of the presence of ATP in intracellular compartments, it has existed in the eukaryotic progenitor since the time that intracellular membranes were first used for protein secretion to drive protein folding and maturation. We suppose that eventually the release of ATP was harnessed to provide information regarding the cell and to signal to other cells through the appearance of purinergic receptors. Purinergic responses are already present in Paramecium (67) . We suggest that the presence of Mcd4p led to the release of ATP extracellularly and the evolution of purinergic receptors. The discovery of the involvement of the Mcd4p protein family, the V-ATPase, and membrane trafficking in ATP release has opened a new avenue to study nucleotide movement across cellular membranes and the modulation of purinergic signaling.
